These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 8564217)

  • 1. 5-HT3 receptor agonist induced carrier-mediated release of dopamine in rat striatum in vivo.
    Santiago M; Machado A; Cano J
    Br J Pharmacol; 1995 Sep; 116(1):1545-50. PubMed ID: 8564217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of serotoninergic drugs on in vivo dopamine extracellular output in rat striatum.
    Santiago M; Matarredona ER; Machado A; Cano J
    J Neurosci Res; 1998 Jun; 52(5):591-8. PubMed ID: 9632315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of age and dopamine agonists and antagonists on striatal dopamine release in the rat: an in vivo microdialysis study.
    Santiago M; Machado A; Cano J
    Mech Ageing Dev; 1993 Apr; 67(3):261-7. PubMed ID: 7686993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. d-fenfluramine increases striatal extracellular dopamine in vivo independently of serotonergic terminals or dopamine uptake sites.
    De Deurwaerdère P; Bonhomme N; Le Moal M; Spampinato U
    J Neurochem; 1995 Sep; 65(3):1100-8. PubMed ID: 7543929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complex I inhibitor effect on the nigral and striatal release of dopamine in the presence and absence of nomifensine.
    Santiago M; Granero L; Machado A; Cano J
    Eur J Pharmacol; 1995 Jul; 280(3):251-6. PubMed ID: 8566093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 5-HT1A receptor antagonist (S)-UH-301 decreases dopamine release in the rat nucleus accumbens and striatum.
    Nomikos GG; Arborelius L; Höök BB; Hacksell U; Svensson TH
    J Neural Transm (Vienna); 1996; 103(5):541-54. PubMed ID: 8811500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of angiotensin II on dopamine and serotonin turnover in the striatum of conscious rats.
    Mendelsohn FA; Jenkins TA; Berkovic SF
    Brain Res; 1993 Jun; 613(2):221-9. PubMed ID: 7514480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nigral and striatal comparative study of the neurotoxic action of 1-methyl-4-phenylpyridinium ion: involvement of dopamine uptake system.
    Santiago M; Machado A; Cano J
    J Neurochem; 1996 Mar; 66(3):1182-90. PubMed ID: 8769882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo characterization of locally applied dopamine uptake inhibitors by striatal microdialysis.
    Nomikos GG; Damsma G; Wenkstern D; Fibiger HC
    Synapse; 1990; 6(1):106-12. PubMed ID: 1697988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of the striatal dopaminergic neuron system by carbon monoxide exposure in free-moving rats, as determined by in vivo brain microdialysis.
    Hara S; Mukai T; Kurosaki K; Kuriiwa F; Endo T
    Arch Toxicol; 2002 Oct; 76(10):596-605. PubMed ID: 12373456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine and glutamate release in the nucleus accumbens and ventral tegmental area of rat following lateral hypothalamic self-stimulation.
    You ZB; Chen YQ; Wise RA
    Neuroscience; 2001; 107(4):629-39. PubMed ID: 11720786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of COMT inhibitors on striatal dopamine metabolism: a microdialysis study.
    Kaakkola S; Wurtman RJ
    Brain Res; 1992 Aug; 587(2):241-9. PubMed ID: 1381981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study.
    Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW
    J Neurochem; 1988 Feb; 50(2):346-55. PubMed ID: 2447237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of transient, global, cerebral ischemia on striatal extracellular dopamine, serotonin and their metabolites.
    Phebus LA; Clemens JA
    Life Sci; 1989; 44(19):1335-42. PubMed ID: 2469926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of harmine on dopamine output and metabolism in rat striatum: role of monoamine oxidase-A inhibition.
    Iurlo M; Leone G; Schilström B; Linnér L; Nomikos G; Hertel P; Silvestrini B; Svensson H
    Psychopharmacology (Berl); 2001 Dec; 159(1):98-104. PubMed ID: 11797076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the prefrontal cortical dopamine release by GABAA and GABAB receptor agonists and antagonists.
    Santiago M; Machado A; Cano J
    Brain Res; 1993 Dec; 630(1-2):28-31. PubMed ID: 7509709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The characterization of the effect of locally applied N-methylquipazine, a 5-HT3 receptor agonist, on extracellular dopamine levels in the anterior medial prefrontal cortex in the rat: an in vivo microdialysis study.
    Kurata K; Ashby CR; Oberlender R; Tanii Y; Kurachi M; Rini NJ; Strecker RE
    Synapse; 1996 Dec; 24(4):313-21. PubMed ID: 10638822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo microdialysis evidence for transient dopamine release by benzazepines in rat striatum.
    Tomiyama K; Koshikawa N; Funada K; Oka K; Kobayashi M
    J Neurochem; 1995 Dec; 65(6):2790-5. PubMed ID: 7595579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YM-09151-2 but not l-sulpiride induces transient dopamine release in rat striatum via a tetrodotoxin-insensitive mechanism.
    Tomiyama K; Noguchi M; Koshikawa N; Kobayashi M
    J Neurochem; 1993 May; 60(5):1690-5. PubMed ID: 8473891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of acute administration of the 5-HT1A receptor ligand, lesopitron, on rat cortical 5-HT and dopamine turnover.
    Ballarín M; Carceller A; Guitart X
    Br J Pharmacol; 1994 Oct; 113(2):425-30. PubMed ID: 7530571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.